pirenzepine has been researched along with Depression, Postpartum in 1 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
Depression, Postpartum: Depression in POSTPARTUM WOMEN, usually within four weeks after giving birth (PARTURITION). The degree of depression ranges from mild transient depression to neurotic or psychotic depressive disorders. (From DSM-IV, p386)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Croke, S | 1 |
| Buist, A | 1 |
| Hackett, LP | 1 |
| Ilett, KF | 1 |
| Norman, TR | 1 |
| Burrows, GD | 1 |
1 trial available for pirenzepine and Depression, Postpartum
| Article | Year |
|---|---|
Olanzapine excretion in human breast milk: estimation of infant exposure.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Depression, Postpartum; Female; Humans; Infant; Infant | 2002 |